UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

Value in health, 2014-05, Vol.17 (3), p.A12-A12

2014

Volltextzugriff (PDF)

PMD15 - Thrombectomy in the treatment of acute ischemic stroke: what effects do methodological differences in trial design have on comparability of outcomes?

Value in health, 2015-11, Vol.18 (7), p.A346-A346

2015

Volltextzugriff (PDF)

Thrombectomy in the treatment of acute ischemic stroke: what effects do methodological differences in trial design have on comparability of outcomes?

Value in health, 2015-11, Vol.18 (7), p.A346-A346

2015

Volltextzugriff (PDF)

PHP14 - Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

Value in health, 2014-05, Vol.17 (3), p.A12-A12

2014

Volltextzugriff (PDF)

PHP241 - A Handbook and a Toolkit for Hospital-Based Health Technology Assessment

Value in health, 2015-11, Vol.18 (7), p.A556-A556

2015

Volltextzugriff (PDF)

A Handbook and a Toolkit for Hospital-Based Health Technology Assessment

Value in health, 2015-11, Vol.18 (7), p.A556-A556

2015

Volltextzugriff (PDF)

PMD10 GENETIC TESTING, PREDICTIVE GENETIC TESTING FOR HEREDITARY CANCER

Value in health, 2003-11, Vol.6 (6), p.794-795

2003

Volltextzugriff (PDF)

Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report

Value in health, 2009-06, Vol.12 (4), p.430-440

2009

Volltextzugriff (PDF)

PCR9 Health Care Use and Out-of-Pocket Costs after a Transitional Palliative Care Intervention for Rural Family Caregivers and Care Recipients: A Randomized Controlled Trial

Value in health, 2023-06, Vol.26 (6), p.S313-S313

2023

Volltextzugriff (PDF)

PCN328 Work Productivity and Activity Impairment in HR+/HER2– EARLY STAGE Breast Cancer

Value in health, 2020-12, Vol.23, p.S480-S480

2020

Volltextzugriff (PDF)

PMS61 Estimation of Health Utilities for NON-Ambulatory Duchenne Muscular Dystrophy (DMD) Patients and Their Caregivers

Value in health, 2020-12, Vol.23, p.S602-S602

2020

Volltextzugriff (PDF)

POSB41 Real-World Assessment of Healthcare Resource Utilisation and Direct Medical Costs in Patients with COPD Receiving ICS/LABA Therapy in England

Value in health, 2022-01, Vol.25 (1), p.S67-S68

2022

Volltextzugriff (PDF)

POSA78 Real-World Assessment of Healthcare Resource Utilisation and Direct Medical Costs in Patients with COPD Receiving LAMA/LABA Therapy in England

Value in health, 2022-01, Vol.25 (1), p.S48-S48

2022

Volltextzugriff (PDF)

PMC59 CULTURAL AND LINGUISTIC ISSUES ASSOCIATED WITH THE TRANSLATION AND LINGUISTIC VALIDATION OF QUESTIONNAIRES FOR USE IN CHINA

Value in health, 2009, Vol.12 (7), p.A397-A398

2009

Volltextzugriff (PDF)

PMC44 IS A LITERAL BACKTRANSLATION IN PRO DOCUMENTS ALWAYS THE BEST OPTION?

Value in health, 2008, Vol.11 (3), p.A182-A182

2008

Volltextzugriff (PDF)

PMH87 SUPPORTING PRODUCT CLAIMS IN DRUG DEVELOPMENT: A FRAMEWORK FOR INTEGRATING PATIENT REPORTED OUTCOMES AND HEALTH ECONOMICS CONCEPTS AND ENDPOINTS

Value in health, 2008, Vol.11 (3), p.A136-A136

2008

Volltextzugriff (PDF)

Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

Value in health, 2019-06, Vol.22 (6), p.712-720

2019

Volltextzugriff (PDF)

PMC85 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE PAR-ENT-QOL QUESTIONNAIRE

Value in health, 2009, Vol.12 (3), p.A35-A35

2009

Volltextzugriff (PDF)

PMC64 DIFFICULTIES WITH THE APPLICATION OF PRO MEASURES TO CULTURES OUTSIDE OF WESTERN EUROPE AND NORTH AMERICA IN MULTI-NATIONAL TRIALS

Value in health, 2009, Vol.12 (7), p.A398-A399

2009

Volltextzugriff (PDF)

PMC76 AN ASSESSMENT OF THE EVIDENCE TO SUPPORT THE USE OF LINGUISTIC VALIDATION INTERVIEWS AS AN INTEGRAL PART OF THE TRANSLATION OF PROS FOR USE IN MULTI-NATIONAL TRIALS

Value in health, 2009, Vol.12 (3), p.A33-A33

2009

Volltextzugriff (PDF)

PMC37 CHALLENGES OF TRANSLATING AND LINGUISTICALLY VALIDATING PRO MEASURES INTO SLAVIC LANGUAGES

Value in health, 2008, Vol.11 (6), p.A570-A570

2008

Volltextzugriff (PDF)

PR5 TRANSLATION AND LINGUISTIC VALIDATION: EVIDENCE TO SUGGEST THAT AN IN-COUNTRY REVIEW IS NECESSARY

Value in health, 2009, Vol.12 (7), p.A235-A235

2009

Volltextzugriff (PDF)

PMC67 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE SUBJECTIVE WELL-BEING UNDER NEUROLEPTICS – SHORT VERSION (SWN-S) QUESTIONNAIRE

Value in health, 2009, Vol.12 (3), p.A32-A32

2009

Volltextzugriff (PDF)

PMC35 THE ISSUES THAT ARISE DURING THE TRANSLATION OF IVRS (INTERACTIVE VOICE RESPONSE SYSTEM) EPRO SCRIPTS

Value in health, 2007, Vol.10 (3), p.A194-A194

2007

Volltextzugriff (PDF)

PMC18 THE ROLE OF CONCEPTUAL MODELS, ENDPOINT MODELS, AND CONCEPTUAL FRAMEWORKS WHEN MAKING TREATMENT BENEFIT CLAIMS TO THE FDA

Value in health, 2007, Vol.10 (6), p.A456-A456

2007

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieValue In Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley-Blackwell Journals
(29)
EZB Electronic Journals Library
(29)
Journals@Ovid Complete
(29)
Ingenta.com
(29)
Elsevier ScienceDirect Journals Complete
(29)
IngentaConnect Journals
(15)
Applied Social Sciences Index & Abstracts (ASSIA)
(2)
MEDLINE
(2)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

PMD15 - Thrombectomy in the treatment of acute ischemic stroke: what effects do methodological differences in trial design have on comparability of outcomes?

Thrombectomy in the treatment of acute ischemic stroke: what effects do methodological differences in trial design have on comparability of outcomes?

PHP14 - Divergent Evidence Requirements Comparing The Authorization And Reimbursement Processes Of High-Risk Medical Devices – The European Situation

PHP241 - A Handbook and a Toolkit for Hospital-Based Health Technology Assessment

A Handbook and a Toolkit for Hospital-Based Health Technology Assessment

PMD10 GENETIC TESTING, PREDICTIVE GENETIC TESTING FOR HEREDITARY CANCER

Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report

PCR9 Health Care Use and Out-of-Pocket Costs after a Transitional Palliative Care Intervention for Rural Family Caregivers and Care Recipients: A Randomized Controlled Trial

PCN328 Work Productivity and Activity Impairment in HR+/HER2– EARLY STAGE Breast Cancer

PMS61 Estimation of Health Utilities for NON-Ambulatory Duchenne Muscular Dystrophy (DMD) Patients and Their Caregivers

POSB41 Real-World Assessment of Healthcare Resource Utilisation and Direct Medical Costs in Patients with COPD Receiving ICS/LABA Therapy in England

POSA78 Real-World Assessment of Healthcare Resource Utilisation and Direct Medical Costs in Patients with COPD Receiving LAMA/LABA Therapy in England

PMC59 CULTURAL AND LINGUISTIC ISSUES ASSOCIATED WITH THE TRANSLATION AND LINGUISTIC VALIDATION OF QUESTIONNAIRES FOR USE IN CHINA

PMC44 IS A LITERAL BACKTRANSLATION IN PRO DOCUMENTS ALWAYS THE BEST OPTION?

PMH87 SUPPORTING PRODUCT CLAIMS IN DRUG DEVELOPMENT: A FRAMEWORK FOR INTEGRATING PATIENT REPORTED OUTCOMES AND HEALTH ECONOMICS CONCEPTS AND ENDPOINTS

Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages

PMC85 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE PAR-ENT-QOL QUESTIONNAIRE

PMC64 DIFFICULTIES WITH THE APPLICATION OF PRO MEASURES TO CULTURES OUTSIDE OF WESTERN EUROPE AND NORTH AMERICA IN MULTI-NATIONAL TRIALS

PMC76 AN ASSESSMENT OF THE EVIDENCE TO SUPPORT THE USE OF LINGUISTIC VALIDATION INTERVIEWS AS AN INTEGRAL PART OF THE TRANSLATION OF PROS FOR USE IN MULTI-NATIONAL TRIALS

PMC37 CHALLENGES OF TRANSLATING AND LINGUISTICALLY VALIDATING PRO MEASURES INTO SLAVIC LANGUAGES

PR5 TRANSLATION AND LINGUISTIC VALIDATION: EVIDENCE TO SUGGEST THAT AN IN-COUNTRY REVIEW IS NECESSARY

PMC67 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE SUBJECTIVE WELL-BEING UNDER NEUROLEPTICS – SHORT VERSION (SWN-S) QUESTIONNAIRE

PMC35 THE ISSUES THAT ARISE DURING THE TRANSLATION OF IVRS (INTERACTIVE VOICE RESPONSE SYSTEM) EPRO SCRIPTS

PMC18 THE ROLE OF CONCEPTUAL MODELS, ENDPOINT MODELS, AND CONCEPTUAL FRAMEWORKS WHEN MAKING TREATMENT BENEFIT CLAIMS TO THE FDA

Aktive Filter

Suchergebnisse filtern